Analysts see high-risk, high-reward potential in Red Cat Holdings, Taysha Gene Therapies, and Solaris Resources, each projected to roughly double despite significant company-specific risks.
Nathan Reiff is a Contributing Author at MarketBeat. He specializes in finance and personal finance, covering topics such as cryptocurrency, trading, and retirement planning, with a keen interest in the intersection of technology and finance. Nathan's insights and expertise have been featured in prominent outlets including TipRanks, Yahoo Finance, and Entrepreneur.